Compare PFIS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFIS | CATX |
|---|---|---|
| Founded | 1905 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.6M | 497.9M |
| IPO Year | 1998 | 2018 |
| Metric | PFIS | CATX |
|---|---|---|
| Price | $56.08 | $3.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $56.00 | $12.11 |
| AVG Volume (30 Days) | 61.2K | ★ 1.5M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | ★ 493.94 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $5.85 | N/A |
| P/E Ratio | $39.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.77 | $1.96 |
| 52 Week High | $59.86 | $6.16 |
| Indicator | PFIS | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 43.57 |
| Support Level | $49.34 | $3.50 |
| Resistance Level | $59.02 | $3.89 |
| Average True Range (ATR) | 2.08 | 0.28 |
| MACD | -0.21 | 0.01 |
| Stochastic Oscillator | 52.84 | 41.14 |
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, equipment finance, working capital lines of credit, and construction loans, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.